| Financial Year |
March 31 2023 |
| Monetary Funds |
660,019,258.49 |
| Held-for-trading Financial Assets |
19,594,088.62 |
| Notes Receivable |
7,918,210.28 |
| Accounts Receivable |
958,461,131.40 |
| Advances to Suppliers |
61,245,755.84 |
| Other Receivables |
19,755,990.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,662,604,537.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
73,448,983.94 |
| Total Current Assets |
3,541,928,303.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
908,121.33 |
| Long-term Equity Investment |
4,323,145.07 |
| Investment Properties |
44,888,806.72 |
| Fixed Assetes |
546,863,367.33 |
| Under-construction Projects |
145,936,123.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
75,111,754.11 |
| R&D expenses |
-- |
| Goodwill |
364,910,592.73 |
| Long-Term Deferred and Prepaid Expenses |
1,635,625.69 |
| Deferred Income Tax Assets |
31,757,967.27 |
| Other Non-Current Assets |
73,442,697.26 |
| Sub-Total of Non-Current Assets |
1,303,423,113.14 |
| Total Assets |
4,845,351,416.72 |
| Short-Term Loans |
654,224,836.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
360,820,281.80 |
| Accounts Payable |
644,984,234.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
149,915,705.15 |
| Taxes Payable |
56,028,353.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
143,580,387.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
89,059,408.49 |
| Other Current Liabilities |
49,850,725.62 |
| Sub-Total of Current Liabilities |
2,766,557,149.17 |
| Long-term Loans |
234,457,455.56 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,066,708.73 |
| Deferred Income Tax Liabilities |
2,460,698.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
245,852,478.53 |
| Total Liabilities |
3,012,409,627.70 |
| Paid-In Capital(Or Share Stock) |
190,734,648.00 |
| Capital Surplus |
841,613,032.17 |
| Surplus Reserve |
89,299,582.51 |
| LESS:Treasury Stock |
85,002,020.00 |
| Undistributed Profits |
743,072,072.99 |
| Minority Stockholder's Interest |
69,484,499.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,763,457,289.75 |
| Owner's Equity（Stockholder's Equity） |
1,832,941,789.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,845,351,416.72 |
